2024/12/12 by Tuti Meihartati, Leny Suzana Suddin, Zatul Akmar Ahmad · 1 voice
Medicine · #Anesthesia and Pain Management #Nausea and vomiting management #Pregnancy and Medication Impact
paper · pdf · doi:10.4081/hls.2024.13145
openalex publication_date 2024/12/12 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/17
Pregnancy can lead to nausea and vomiting, commonly affecting women during the first trimester but sometimes continuing throughout the entire pregnancy. This study utilized a quantitative, non-equivalent control group design, a prevalent approach in quasi-experimental research. It involved 120 pregnant women between 6 and 16 weeks of gestation who were experiencing moderate to severe symptoms of nausea and vomiting in pregnancy (NVP). Participants were recruited from four private maternity clinics in Samarinda, Indonesia. The study was registered with the Indonesia Clinical Research Registry (INA-DOBP5OS0). The results indicated that the Pregnancy-Unique Quantification of Emesis (PUQE) scores for the participants in the intervention group were significantly lower than those in the control group after the intervention period (P<0.01). Furthermore, no adverse effects were reported following the intervention. Regarding the satisfaction variable, the study found that the dual methods of P6 acupressure resulted in a statistically significant improvement in satisfaction among pregnant women with NVP (Z=1830, P<0.01). Based on our findings, the use of dual P6 acupressure, which includes both pressure application and an acupressure band, is effective in reducing nausea and vomiting experienced by pregnant women.